These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 7882331

  • 1. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
    Zhou BS, Hsu NY, Pan BC, Doroshow JH, Yen Y.
    Cancer Res; 1995 Mar 15; 55(6):1328-33. PubMed ID: 7882331
    [Abstract] [Full Text] [Related]

  • 2. Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells.
    Zhou BS, Ker R, Ho R, Yu J, Zhao YR, Shih J, Yen Y.
    Biochem Pharmacol; 1998 May 15; 55(10):1657-65. PubMed ID: 9634002
    [Abstract] [Full Text] [Related]

  • 3. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK, McClarty GA, Chan AK, Thelander L, Wright JA.
    Cancer Res; 1988 Apr 15; 48(8):2029-35. PubMed ID: 2832057
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine.
    Yen Y, Grill SP, Dutschman GE, Chang CN, Zhou BS, Cheng YC.
    Cancer Res; 1994 Jul 15; 54(14):3686-91. PubMed ID: 7518343
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA.
    Chen S, Zhou B, He F, Yen Y.
    Antisense Nucleic Acid Drug Dev; 2000 Apr 15; 10(2):111-6. PubMed ID: 10805162
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.
    Zhou BS, Tsai P, Ker R, Tsai J, Ho R, Yu J, Shih J, Yen Y.
    Clin Exp Metastasis; 1998 Jan 15; 16(1):43-9. PubMed ID: 9502076
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
    Kuo ML, Hwang HS, Sosnay PR, Kunugi KA, Kinsella TJ.
    Cancer J; 2003 Jan 15; 9(4):277-85. PubMed ID: 12967138
    [Abstract] [Full Text] [Related]

  • 8. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
    Moscow JA, Townsend AJ, Cowan KH.
    Mol Pharmacol; 1989 Jul 15; 36(1):22-8. PubMed ID: 2747627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
    Albert DA, Nodzenski E, Yim G, Kowalski J.
    J Cell Physiol; 1990 May 15; 143(2):251-6. PubMed ID: 2159014
    [Abstract] [Full Text] [Related]

  • 11. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL, Cory JG.
    Cancer Res; 1988 Oct 15; 48(20):5796-9. PubMed ID: 2844392
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms responsible for the drug-induced posttranscriptional modulation of ribonucleotide reductase levels in a hydroxyurea-resistant mouse L cell line.
    McClarty GA, Chan AK, Choy BK, Thelander L, Wright JA.
    Biochemistry; 1988 Sep 20; 27(19):7524-31. PubMed ID: 3061459
    [Abstract] [Full Text] [Related]

  • 14. Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells.
    Hurta RA, Wright JA.
    Biochem Biophys Res Commun; 1990 Feb 28; 167(1):258-64. PubMed ID: 2178608
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elevated expression of M1 and M2 components and drug-induced posttranscriptional modulation of ribonucleotide reductase in a hydroxyurea-resistant mouse cell line.
    McClarty GA, Chan AK, Engstrom Y, Wright JA, Thelander L.
    Biochemistry; 1987 Dec 01; 26(24):8004-11. PubMed ID: 2827767
    [Abstract] [Full Text] [Related]

  • 18. Mammalian drug resistant mutants with multiple gene amplifications: genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5-8, the H-subunit of ferritin and the L-subunit of ferritin.
    Hurta RA, Wright JA.
    Biochim Biophys Acta; 1990 Oct 23; 1087(2):165-72. PubMed ID: 2223878
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase.
    Li Q, Kasten-Jolly J, Yen Y, Freed BM.
    Toxicol Appl Pharmacol; 1998 May 23; 150(1):154-7. PubMed ID: 9630464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.